Liver Fat, Statin Use, and Incident Diabetes: The Multi-Ethnic Study of Atherosclerosis

BACKGROUND AND AIMS: To balance competing cardiovascular benefits and metabolic risks of statins, markers of type 2 diabetes (T2D) susceptibility are needed. We sought to define a competing risk/benefit of statin therapy on T2D and cardiovascular disease (CVD) events using liver attenuation and coro...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Atherosclerosis
Asıl Yazarlar: Shah, Ravi V., Allison, Matthew A., Lima, Joao A.C., Bluemke, David A., Abbasi, Siddique A., Ouyang, Pamela, Jerosch-Herold, Michael, Ding, Jingzhong, Budoff, Matthew J., Murthy, Venkatesh L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4546884/
https://ncbi.nlm.nih.gov/pubmed/26209814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.atherosclerosis.2015.07.018
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller